All In Biotech

Drug Trial Radar · NCT06568367

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Solriamfetol in Excessive Sleepiness Associated With Shift Work Disorder

Last checked: Nov 20, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

520

Planned (sponsor's estimate)

Start

Aug 1, 2024

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

SUSTAIN (Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with excessive sleepiness associated with shift work disorder (SWD).

Conditions

  • Excessive Sleepiness
  • Shift-work Disorder

Interventions

  • Solriamfetol 150 mgDrug

    Solriamfetol tablets, taken once daily

  • Solriamfetol 300 mgDrug

    Solriamfetol tablets, taken once daily

  • PlaceboDrug

    Placebo tablets, taken once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline to Week 12 in the mean sleep latency time as measured by the Maintenance of Wakefulness Test (MWT).Time frame: 12 weeks
  2. Change from Baseline to Week 12 in the Clinical Global Impressions of Severity of Illness (CGI-S) for sleepiness during the night shift.Time frame: 12 weeks

Locations

49 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinical Research Site

    Auburn, Alabama · Recruiting

  • Clinical Research Site

    Cullman, Alabama · Recruiting

  • Clinical Research Site

    Chandler, Arizona · Recruiting

  • Clinical Research Site

    Tucson, Arizona · Withdrawn

  • Clinical Research Site

    Little Rock, Arkansas · Recruiting

  • Clinical Research Site

    Anaheim, California · Recruiting

  • Clinical Research Site

    Cerritos, California · Recruiting

  • Clinical Research Site

    Chula Vista, California · Terminated

  • Clinical Research Site

    Huntington Beach, California · Recruiting

  • Clinical Research Site

    Long Beach, California · Recruiting

  • Clinical Research Site

    Santa Ana, California · Recruiting

  • Clinical Research Site

    Colorado Springs, Colorado · Recruiting

  • Clinical Research Site

    Brandon, Florida · Recruiting

  • Clinical Research Site

    Hialeah, Florida · Recruiting

  • Clinical Research Site

    Miami, Florida · Recruiting

  • Clinical Research Site

    Miami, Florida · Withdrawn

  • Clinical Research Site

    Miami, Florida · Recruiting

  • Clinical Research Site

    Miami Lakes, Florida · Recruiting

  • Clinical Research Site

    Atlanta, Georgia · Recruiting

  • Clinical Research Site

    Stockbridge, Georgia · Recruiting

  • Clinical Research Site

    Chicago, Illinois · Recruiting

  • Clinical Research Site

    Kenner, Louisiana · Recruiting

  • Clinical Research Site

    Towson, Maryland · Recruiting

  • Clinical Research Site

    Boston, Massachusetts · Recruiting

  • Clinical Research Site

    Lansing, Michigan · Recruiting

  • Clinical Research Site

    Novi, Michigan · Recruiting

  • Clinical Research Site

    Southfield, Michigan · Recruiting

  • Clinical Research Site

    Chesterfield, Missouri · Recruiting

  • Clinical Research Site

    St Louis, Missouri · Recruiting

  • Clinical Research Site

    Henderson, Nevada · Recruiting

  • Clinical Research Site

    Middletown, New Jersey · Recruiting

  • Clinical Research Site

    Denver, North Carolina · Recruiting

  • Clinical Research Site

    Fayetteville, North Carolina · Recruiting

  • Clinical Research Site

    Huntersville, North Carolina · Recruiting

  • Clinical Research Site

    Cincinnati, Ohio · Recruiting

  • Clinical Research Site

    Cincinnati, Ohio · Recruiting

  • Clinical Research Site

    Wyomissing, Pennsylvania · Recruiting

  • Clinical Research Site

    Charleston, South Carolina · Recruiting

  • Clinical Research Site

    Columbia, South Carolina · Recruiting

  • Clinical Research Site

    Houston, Texas · Recruiting

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.